Skip to main content
GoodMoatv1.3
Sign in
NXL logo

NXL

CompareEarnings: May 31, 2026

Nexalin Technology Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Devices

Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman.

Did you know?

Holds 654783.0x more cash than debt — a strong balance sheet.

Current Price

$0.38

+0.03%

GoodMoat Value

$0.08

79.4% overvalued
Profile
Valuation (TTM)
Market Cap$7.10M
P/E-0.86
EV—
P/B1.89
Shares Out18.65M
P/Sales23.52
Revenue$301647.00
EV/EBITDA—

Nexalin Technology Inc (NXL) Company Profile

NXL Company Information

Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.

All of Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues.

Nexalin utilizes bioelectronic medical technology to treat mental health issues.

Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders.

Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects.

The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman.

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

Country

Texas, USA

NXL Key Officers

Key officers data coming soon

NXL Company Profile

Nexalin Technology Inc (NXL) is a Healthcare company in the Medical Devices industry. It trades on NASDAQ. The company is based in Texas, USA.

Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman.

Market cap is $7.10M. There are 18.7M shares outstanding.

See the full Nexalin Technology Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if NXL is a good investment.